Cascade Infectious Diseases and Infusion LLC

Cascade Infectious Diseases and Infusion LLC was paid $9.57M by Medicaid between Jan 2018 and Dec 2024, across 43 billing codes. Its largest line is 96521, — 23% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	28,803	$2.02M
2019	29,092	$1.88M
2020	23,836	$1.58M
2021	24,701	$1.52M
2022	16,386	$1.07M
2023	16,154	$859K
2024incomplete	13,629	$634K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
96521		23%	15,293	2,427	$2.19M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	21%	32,435	7,614	$2.02M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	12%	13,989	10,337	$1.16M
J0878	Injection, daptomycin, 1 mg	8.0%	14,060	2,294	$768K
A6253	Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing	7.5%	6,398	1,797	$717K
J1335	Injection, ertapenem sodium, 500 mg	6.9%	12,863	2,270	$663K
99232	Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity	5.9%	12,440	4,246	$561K
99223	Prolong inpt eval add15 m	4.1%	3,212	2,831	$391K
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	3.3%	8,412	1,421	$318K
A6252	Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing	1.8%	2,198	945	$175K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	1.1%	46	40	$103K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	2,725	634	$86K

31 more codes

99215	Doctor's office visit, returning patient (complex)	<1%	466	$49K
A4649	Surgical supply; miscellaneous	<1%	8,891	$46K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	15	$39K
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	<1%	121	$33K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	187	$31K
99205	Prolong outpt/office vis	<1%	175	$29K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	412	$27K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,138	$18K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,434	$17K
99222	Initial hospital care, per day, moderate complexity	<1%	150	$16K
36415	Collection of venous blood by venipuncture	<1%	5,598	$14K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	57	$13K
96368		<1%	851	$12K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	111	$10K
80053	Comprehensive metabolic panel	<1%	1,240	$9K
96415		<1%	172	$8K
29581		<1%	149	$7K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	1,394	$7K
J3370	Injection, vancomycin hcl, 500 mg	<1%	360	$6K
36569		<1%	15	$4K
99213	Doctor's office visit, returning patient (routine)	<1%	93	$4K
86140		<1%	878	$3K
85651		<1%	949	$3K
99204	Doctor's office visit, new patient (more involved)	<1%	12	$2K
36589		<1%	15	$2K
11721		<1%	44	$932.36
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	31	$797.51
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	27	$648.83
82550		<1%	84	$339.87
0012A		<1%	14	$328.00
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	447	$133.17

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGIROD, JOHN (OWNER)